Dashboard
1
With a growth in Net Profit of 52.74%, the company declared Very Positive results in Sep 25
- The company has declared positive results in Jan 70 after 2 consecutive negative quarters
- OPERATING CASH FLOW(Y) Highest at CNY 2,076.91 MM
- RAW MATERIAL COST(Y) Fallen by -10.01% (YoY)
- INVENTORY TURNOVER RATIO(HY) Highest at 3.65 times
2
With ROE of -2.28%, it has a risky valuation with a 0.90 Price to Book Value
Stock DNA
Chemicals & Petrochemicals
CNY 10,075 Million (Mid Cap)
NA (Loss Making)
NA
3.93%
0.53
-0.56%
1.04
Revenue and Profits:
Net Sales:
2,819 Million
(Quarterly Results - Mar 2026)
Net Profit:
241 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-11.45%
0%
-11.45%
6 Months
-3.56%
0%
-3.56%
1 Year
18.49%
0%
18.49%
2 Years
2.53%
0%
2.53%
3 Years
-8.46%
0%
-8.46%
4 Years
-5.62%
0%
-5.62%
5 Years
-22.94%
0%
-22.94%
Huapont Life Sciences Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
2.41%
EBIT Growth (5y)
-23.59%
EBIT to Interest (avg)
2.71
Debt to EBITDA (avg)
3.00
Net Debt to Equity (avg)
0.62
Sales to Capital Employed (avg)
0.59
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.76%
ROE (avg)
8.29%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.90
EV to EBIT
60.62
EV to EBITDA
9.79
EV to Capital Employed
0.93
EV to Sales
1.12
PEG Ratio
NA
Dividend Yield
4.50%
ROCE (Latest)
1.54%
ROE (Latest)
-2.28%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,818.70
2,426.40
16.17%
Operating Profit (PBDIT) excl Other Income
362.40
354.90
2.11%
Interest
55.40
84.80
-34.67%
Exceptional Items
-1.80
2.20
-181.82%
Consolidate Net Profit
240.90
1.80
13,283.33%
Operating Profit Margin (Excl OI)
128.60%
12.00%
11.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 16.17% vs -22.75% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 13,283.33% vs -99.45% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
11,464.70
11,621.80
-1.35%
Operating Profit (PBDIT) excl Other Income
2,509.10
2,094.50
19.79%
Interest
324.60
369.50
-12.15%
Exceptional Items
-103.20
-819.20
87.40%
Consolidate Net Profit
881.20
-342.60
357.21%
Operating Profit Margin (Excl OI)
111.80%
89.40%
2.24%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is -1.35% vs 0.66% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 357.21% vs -150.61% in Dec 2024
About Huapont Life Sciences Co., Ltd. 
Huapont Life Sciences Co., Ltd.
Chemicals & Petrochemicals
No Details Available.
Company Coordinates 
No Company Details Available






